Pharmaceutical compounding (503B) is compounding pharmacies with outsourcing facilities that may manufacture large batches with or without prescriptions to be sold to healthcare facilities for office use only. 503B compounding pharmacies that provide patient-specific medications are held to higher regulatory standards. These facilities must comply with current good manufacturing practices (CGMP).
Community Discussions
Community Discussions
Jun 29, 2024
Information Systems
Manufacturing Operations
Jun 27, 2024
Manufacturing Operations
Validation
Jun 25, 2024
Quality
Quality Assurance
Jun 13, 2024
Information Systems
Regulatory
Advanced Manufacturing
Active Pharmaceutical Ingredients
May 30, 2024
May 29, 2024
Manufacturing Operations
May 29, 2024
Manufacturing Operations